Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells

Cell

Volumn 113, Issue 5, 2003, Pages 643-655

  Chambers, Ian ^a   Colby, Douglas ^a   Robertson, Morag ^a   Nichols, Jennifer ^a   Lee, Sonia ^a   Tweedie, Susan ^a   Smith, Austin ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HOMEODOMAIN PROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; PROTEIN NANOG; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL LEVEL; CELL LINE; CELL RENEWAL; CELL STIMULATION; CELLULAR PARAMETERS; CLONING; EMBRYO CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLEURIPOTENCY; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA ANALYSIS; STEM CELL; TRANSGENE;

ANIMALIA;

EID: 0038143611     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00392-1     Document Type: Article

References (48)

1. Ashfield R., Patel A.J., Bossone S.A., Brown H., Campbell R.D., Marcu K.B., Proudfoot N.J. MAZ-dependent termination between closely spaced human complement genes. EMBO J. 13:1994;5656-5667.
2. Aubert J., Dunstan H., Chambers I., Smith A. Functional gene screening in embryonic stem cells implicates Wnt antagonism in neural differentiation. Nat. Biotechnol. 20:2002;1240-1245.
3. Avilion A.A., Nicolis S.K., Pevny L.H., Perez L., Vivian N., Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17:2003;126-140.
4. Brook F.A., Gardner R.L. The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA. 94:1997;5709-5712.
5. Burdon T., Chambers I., Stracey C., Niwa H., Smith A. Signaling mechanisms regulating self-renewal and differentiation of pluripotent embryonic stem cells. Cells Tissues Organs. 165:1999;131-143. a.
6. Burdon T., Stracey C., Chambers I., Nichols J., Smith A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev. Biol. 210:1999;30-43. b.
7. Chambers I., Cozens A., Broadbent J., Robertson M., Lee M., Li M., Smith A. Structure of the mouse leukaemia inhibitory factor receptor gene. regulated expression of mRNA encoding a soluble receptor isoform from an alternative 5′ untranslated region Biochem. J. 328:1997;879-888.
8. Dani C., Chambers I., Johnstone S., Robertson M., Ebrahimi B., Saito M., Taga T., Li M., Burdon T., Nichols J., Smith A. Paracrine induction of stem cell renewal by LIF-deficient cells. a new ES cell regulatory pathway Dev. Biol. 203:1998;149-162.
9. Dudley D.T., Pang L., Decker S.J., Bridges A.J., Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92:1995;7686-7689.
10. Evans M.J., Kaufman M. Establishment in culture of pluripotential cells from mouse embryos. Nature. 292:1981;154-156.
11. Fuhrmann G., Chung A.C., Jackson K.J., Hummelke G., Baniahmad A., Sutter J., Sylvester I., Schöler H.R., Cooney A.J. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev. Cell. 1:2001;377-387.
12. Galli G., Hofstetter H., Birnstiel M.L. Two conserved sequence blocks within eukaryotic tRNA genes are major promoter elements. Nature. 294:1981;626-631.
13. Gassmann M., Donoho G., Berg P. Maintenance of an extrachromosomal plasmid vector in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA. 92:1995;1292-1296.
14. Hanna L.A., Foreman R.K., Tarasenko I.A., Kessler D.S., Labosky P.A. Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryo. Genes Dev. 16:2002;2650-2661.
15. Hirano T., Ishihara K., Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene. 19:2000;2548-2556.
16. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R. A stem cell molecular signature. Science. 298:2002;601-604.
17. Jiang Y., Jahagirdar B.N., Reinhardt R.L., Schwartz R.E., Keene C.D., Ortiz-Gonzalez X.R., Reyes M., Lenvik T., Lund T., Blackstad M.et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 418:2002;41-49.
18. Li M., Sendtner M., Smith A. Essential function of LIF receptor in motor neurons. Nature. 378:1995;724-727.
19. Li M., Pevny L., Lovell-Badge R., Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr. Biol. 8:1998;971-974.
20. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA. 78:1981;7634-7638.
21. Matsuda T., Nakamura T., Nakao K., Arai T., Katsuki M., Heike T., Yokota T. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J. 18:1999;4261-4269.
22. Matsui Y., Zsebo K., Hogan B.L.M. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell. 70:1992;841-847.
23. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell. 113:2003;631-642. this issue.
24. Mountford P., Zevnik B., Duwel A., Nichols J., Li M., Dani C., Robertson M., Chambers I., Smith A. Dicistronic targeting constructs. reporters and modifiers of mammalian gene expression Proc. Natl. Acad. Sci. USA. 91:1994;4303-4307.
25. Nichols J., Zevnik B., Anastassiadis K., Niwa H., Klewe-Nebenius D., Chambers I., Schöler H., Smith A. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell. 95:1998;379-391.
26. Nichols J., Chambers I., Taga T., Smith A.G. Physiological rationale for responsiveness of mouse epiblast and embryonic stem cells to gp130 cytokines. Development. 128:2001;2333-2339.
27. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct. Funct. 26:2001;137-148.
28. Niwa H., Burdon T., Chambers I., Smith A.G. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12:1998;2048-2060.
29. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24:2000;372-376.
30. Niwa H., Masui S., Chambers I., Smith A.G., Miyazaki J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22:2002;1526-1536.
31. Pera M.F., Cooper S., Mills J., Parrington J.M. Isolation and characterization of a multipotent clone of human embryonal carcinoma cells. Differentiation. 42:1989;10-23.
32. Pesce M., Schöler H.R. Oct-4. gatekeeper in the beginnings of mammalian development Stem Cells. 19:2001;271-278.
33. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A. "Stemness" transcriptional profiling of embryonic and adult stem cells Science. 298:2002;597-600.
34. Rathjen P.D., Nichols J., Toth S., Edwards D.R., Heath J.K., Smith A.G. Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations. Genes Dev. 4:1990;2308-2318.
35. Resnick J.L., Bixler L.S., Cheng L., Donovan P.J. Long-term proliferation of mouse primordial germ cells in culture. Nature. 359:1992;550-551.
36. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., Bongso A. Embryonic stem cell lines from human blastocysts. somatic differentiation in vitro Nat. Biotechnol. 18:2000;399-404.
37. Ryskov A.P., Ivanov P.L., Kramerov D.A., Georgiev G.P. Mouse ubiquitous B2 repeat in polysomal and cytoplasmic poly(A)+RNAs. uniderectional orientation and 3′-end localization Nucleic Acids Res. 11:1983;6541-6558.
38. Smith A.G. Culture and differentiation of embryonic stem cells. J. Tiss. Cult. Meth. 13:1991;89-94.
39. Smith A. Embryonic Stem Cells. Marshak D.R., Gardner R.L., Gottlieb D. Stem Cell Biology. 2001;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 205-230.pp.
40. Stewart C.L., Kaspar P., Brunet L.J., Bhatt H., Gadi I., Kontgen F., Abbondanzo S.J. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 359:1992;76-79.
41. Takahashi-Tezuka M., Yoshida Y., Fukada T., Ohtani T., Yamanaka Y., Nishida K., Nakajima K., Hibi M., Hirano T. Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol. Cell. Biol. 18:1998;4109-4117.
42. Takeda K., Noguchi K., Shi W., Tanaka T., Matsumoto M., Yoshida N., Kishimoto T., Akira S. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA. 94:1997;3801-3804.
43. Thompson J.E., Cubbon R.M., Cummings R.T., Wicker L.S., Frankshun R., Cunningham B.R., Cameron P.M., Meinke P.T., Liverton N., Weng Y., DeMartino J.A. Photochemical preparation of a pyridone containing tetracycle. a Jak protein kinase inhibitor Bioorg. Med. Chem. Lett. 12:2002;1219-1223.
44. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science. 282:1998;1145-1147.
45. Vernallis A.B., Hudson K.R., Heath J.K. An antagonist for the leukemia inhibitory factor receptor inhibits leukemia inhibitory factor, cardiotrophin-1, ciliary neurotrophic factor, and oncostatin M. J. Biol. Chem. 272:1997;26947-26952.
46. Wang S.-H., Tsai M.-S., Chiang M.-F., Hung L. A novel NK-type homeobox gene, ENK (early embryo specific NK), preferentially expressed in embryonic stem cells. Gene Expression Patterns. 3:2003;99-103.
47. Yoshida K., Chambers I., Nichols J., Smith A., Saito M., Yasukawa K., Shoyab M., Taga T., Kishimoto T. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech. Dev. 45:1994;163-171.
48. Yoshida K., Taga T., Saito M., Suematsu S., Kumanogoh A., Tanaka T., Fujiwara H., Hirata M., Yamagami T., Nakahata T.et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl. Acad. Sci. USA. 93:1996;407-411.